Table 2 ETEST performance based on FDA guidance
Antibiotic | EA (%) | CA (%) | VME* No. (%) | ME* No. (%) | miE* No. (%) | Recalculated miE** No. (%) |
|---|---|---|---|---|---|---|
ATM | 78 | 87 | 0 | 2 (3.3%) | 13 (12.4%) | 5 (4.8%) |
FEP | 72 | 64 | 0 | 5 (9.4%) | 33 (31.4%) | 13 (12.4%) |
CAZ | 82 | 91 | 1 (4.2%) | 0 | 9 (8.6%) | 3 (2.9%) |
CZA | 78 | 93 | 2 (18.2%)/0 (0.0%)* | 5 (5.3%)/2 (2.1%)* | ND | ND |
C/T | 86 | 93 | 0 | 1 (1.4%) | 6 (5.7%) | 1 (1.0%) |
CIP | 79 | 8 | 0 | 0 | 16 (15.2%) | 5 (4.8%) |
LVX | 63 | 83 | 0 | 0 | 18 (17.1%) | 8 (7.6%) |
MEM | 86 | 91 | 0 | 2 (3.3%) | 7 (6.7%) | 3 (2.9%) |
TZP | 77 | 85 | 0 | 2 (2.9%) | 14 (13.3%) | 11 (10.5%) |
TOB | 82 | 81 | 0 | 1 (1.5%) | 19 (18.1%) | 6 (5.7%) |